Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Cost of the Markman delay

As the delay in publishing the Markman ruling extends, how much is it costing PTSC in terms of the commitment to fund legal work (in addition to TPL's normal business of pursuing potential infringers for which they already get 15% of total proceeds)?

If I recall correctly, PTSC is obliged to pay TPL a significant increment until 60 days after the Markman ruling. But what has the increment been funding for, say, the past 45 days other than the re-submission to the Special Master (which in itself is surely on ancillary to Markman and primarily for the Barco litigation)?

Did the infamous "Settlement" with TPL really leave this open-ended? Was any suspension or 'cap' clause negotiated in case of such inactivity because of this delay, which presumably could extend 'at the whim of the Court' - not meant to be a negative comment on the Court but just to expose a possible situation.

I believe the 'confidentiality' of the settlement terms was triggered by a demand by TPL/Leckrone as a condition of 'settling', to which PTSC acquiesced for the sake of expediency.

Share
New Message
Please login to post a reply